These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1648507)

  • 21. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
    Martorelli D; Muraro E; Mastorci K; Dal Col J; Faè DA; Furlan C; Giagulli C; Caccuri F; Rusnati M; Fiorentini S; Carbone A; Caruso A; Dolcetti R
    Int J Cancer; 2015 Sep; 137(6):1374-85. PubMed ID: 25704763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.
    Nikiforow S; Bottomly K; Miller G
    J Virol; 2001 Apr; 75(8):3740-52. PubMed ID: 11264363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of lactic acid in autocrine B-cell growth stimulation.
    Pike SE; Markey SP; Ijames C; Jones KD; Tosato G
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11081-5. PubMed ID: 1662382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.
    Montagnier L; Gruest J; Chamaret S; Dauguet C; Axler C; Guétard D; Nugeyre MT; Barré-Sinoussi F; Chermann JC; Brunet JB
    Science; 1984 Jul; 225(4657):63-6. PubMed ID: 6328661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1-like activity produced by hybrids constructed with Epstein-Barr-virus-transformed human B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Pacciardi A; Tarantino E
    Int Arch Allergy Appl Immunol; 1988; 85(1):76-81. PubMed ID: 2828240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Density-dependent responsiveness to autocrine growth factors of Epstein-Barr virus transformed human B lymphocytes.
    Garzelli C; Bazzichi A; Dayah AM; Manunta M; Incaprera M
    Microbiologica; 1992 Jul; 15(3):303-7. PubMed ID: 1501588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells.
    Buck J; Hämmerling U; Hoffmann MK; Levi E; Welte K
    J Immunol; 1987 May; 138(9):2923-8. PubMed ID: 3033079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
    Wilson AD; Redchenko I; Williams NA; Morgan AJ
    Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.
    Chu E; Umetsu D; Lareau M; Schneeberger E; Geha RS
    Eur J Immunol; 1984 Apr; 14(4):291-8. PubMed ID: 6327319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes.
    Katsumura KR; Maruo S; Takada K
    J Med Virol; 2012 Mar; 84(3):504-10. PubMed ID: 22246839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus.
    Gordon J; Ley SC; Melamed MD; Aman P; Hughes-Jones NC
    J Exp Med; 1984 May; 159(5):1554-9. PubMed ID: 6325575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
    Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
    J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
    Calender A; Billaud M; Aubry JP; Banchereau J; Vuillaume M; Lenoir GM
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8060-4. PubMed ID: 2825176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease.
    Rabin H; Neubauer RH; Hopkins RF; Dzhikidze EK; Shevtsova ZV; Lapin BA
    Intervirology; 1977; 8(4):240-9. PubMed ID: 194867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
    Becker Y; Tabor E; Asher Y
    Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
    Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
    McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
    Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.